EU drugs agency can clear Omicron shot in 4 months if needed

The European Medicines Agency would use expedited procedures to approve new versions of the Covid-19 vaccines to address the omicron variant should the current ones prove insufficient to fight it off.
Photo: Peter Dejong/AP/Ritzau Scanpix
Photo: Peter Dejong/AP/Ritzau Scanpix
By Suzi Ring, Bloomberg

The European Medicines Agency would use expedited procedures to approve new versions of the Covid-19 vaccines to address the omicron variant should the current ones prove insufficient to fight it off.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading